In an article appearing in Science Daily researchers from Virginia Commonwealth University Cancer Center have had a breakthrough in genetic testing that can uncover a biomarker that can predict the relapse of breast cancer.
Tissue samples are taken from the site of the tumor. Specimens were collected from female breast cancer patients and with 85% accuracy they were able to predict if the patient would have a relapse of breast cancer.
The studies lead researcher Dr. Masoud Manili said " our findings could lead to clinical trials that test whether using immunotherapy prior to conventional treatment in breast cancer patients with a high risk of relapse could prime the patients immune system much like a vaccine, to prevent the liklihood of relapse."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment